Patents by Inventor Ariel Boutaud

Ariel Boutaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Laminin-5 gamma2-binding peptides, related compositions, and use thereof
    Publication number: 20070065447
    Abstract: Novel peptides that specifically bind the ?2 chain of laminin-5 and other ?2-associated proteins; related compositions (e.g., derivatives and variants of such peptides; nucleic acids comprising sequences encoding such peptides; pharmaceutical compositions comprising either of such molecules; etc.); methods of using the same for diagnostic, prophylactic, and therapeutic purposes; and additional new and useful related compositions and methods are provided.
    Type: Application
    Filed: April 28, 2006
    Publication date: March 22, 2007
    Applicants: Novo Nordisk A/S, BioStratum Incorporated
    Inventors: Karl Tryggvason, Ida Mathiasen, Soren Padkaer, Svetlana Tarabykina, Sirpa Salo, Ariel Boutaud
  • Recombinant laminin 5
    Patent number: 6703363
    Abstract: The present invention provides recombinant laminin 5, methods for making recombinant laminin 5, cells that express recombinant laminin 5, and methods for using the recombinant laminin 5 to accelerate wound healing, and to promote cell attachment and migration.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: March 9, 2004
    Assignee: BioStratum, Inc.
    Inventor: Ariel Boutaud
  • Recombinant laminin 5
    Publication number: 20040014665
    Abstract: The present invention provides recombinant laminin 5, methods for making recombinant laminin 5, cells that express recombinant laminin 5, and methods for using the recombinant laminin 5 to accelerate wound healing, and to promote cell attachment and migration.
    Type: Application
    Filed: June 25, 2003
    Publication date: January 22, 2004
    Inventor: Ariel Boutaud